A diverse variety of bacteria coexist in the intestines, which is referred to as “intestinal flora.” The types and balance of these bacteria vary by individual, and relationships with many physiological functions such as digestion, metabolism, and immunity have been reported. It is known that the composition of the intestinal flora changes due to lifestyle habits, aging, and the use of medications.<\/p>\n\n\n\n
Fecal Microbiota Transplantation (FMT) is being researched both in Japan and overseas as a medical approach that attempts to adjust the composition of the intestinal flora using bacteria derived from stool collected from healthy donors. Overseas, research is progressing for conditions such as Recurrent Clostridioides difficile infection(rCDI) and Inflammatory bowel disease (IBD), with reports examining its connection to various other diseases.<\/p>\n\n\n\n
FMT is not a treatment involving surgery; rather, the technique has evolved within research aimed at verifying the relationship between changes in the intestinal flora and health status. On the other hand, there is significant individual variation in the composition of the intestinal flora, and this remains a field with many challenges to be addressed regarding donor selection, test items, transplantation methods, and long-term changes.<\/p>\n\n\n\n
In Japan, FMT is not covered by public insurance and is primarily conducted within the framework of clinical studies or private practice (non-insured medical treatment). Knowledge gained from research is accumulating, and efforts to deepen the understanding of the intestinal flora are underway.<\/p>\n\n\n\n
In Japan, research regarding the relationship between the intestinal flora and health\/disease is expanding. In the “Clinical Research and Trials Submission and Registration System” of the Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labour and Welfare, FMT-related research targeting Ulcerative colitis (UC), Recurrent Clostridioides difficile infection(rCDI), Autism Spectrum Disorder (ASD), and liver diseases has been registered, and studies are progressing in a wide range of areas from basic research to clinical studies.<\/p>\n\n\n\n
On the other hand, due to the nature of handling donor stool, FMT is a field that requires cautious operation, including infection control, ethical review, and the setting of test items. For this reason, efforts aimed at standardizing safety and procedures are being advanced in Japan based on the Clinical Research Act.<\/p>\n\n\n\n
The NanoGAS\u00ae-FMT method, adopted by The Association for Clinical Research of Fecal Microbiota Transplantation Japan, is a technique constructed with an emphasis on the standardization of process management and the establishment of a testing system, referencing domestic and international research trends and safety management guidelines. We aim to maintain an appropriate system for private practice across each process: donor selection, testing, manufacturing, storage, and implementation.<\/p>\n\n\n\n
While FMT is a medical approach still implemented within a limited framework in Japan, knowledge regarding safety and procedures is accumulating as research progresses.<\/p>\n\n\n\n
Fecal Microbiota Transplantation (FMT) is a field where institutional frameworks are being developed and research and clinical examinations are being conducted in regions such as Europe, North America, and Australia. Overseas, research targeting Recurrent Clostridioides difficile infection(rCDI) is relatively common, and the U.S. Food and Drug Administration (FDA) treats FMT as an investigational biological product, publishing safety alerts and guidance. Through these measures, standards for infection control and donor selection are becoming clearer.<\/p>\n\n\n\n
In the United States, research infrastructure is being strengthened through the establishment of stool banks by non-profit organizations and the creation of registries where research institutions collect and share case data. Additionally, in Australia, stool-derived products have been approved for specific uses, and institutional development, including quality control and ethical review, is progressing. In Europe, countries are also moving forward with the establishment of stool banks and the preparation of guidelines, with efforts proceeding from both research and institutional management perspectives.<\/p>\n\n\n\n
Globally, research examining the relationship between the intestinal flora and various diseases is increasing, and many related papers are registered in databases such as PubMed. However, the efficacy for each disease and the standardization of procedures are still at a stage requiring further verification.<\/p>\n\n\n\n
These international efforts serve as examples of progress in intestinal flora research and institutional design, providing reference information when considering the research and management systems in Japan.<\/p>\n","protected":false},"excerpt":{"rendered":"
What is Fecal Microbiota Transplantation? A diverse variety of bacteria coexist in the intestines, which is referred to as “intestinal flora.” The types and balance of these bacteria vary by individual, and relationships with many physiological functions such as digestion, metabolism, and immunity have been reported. It is known that the composition of the intestinal […]<\/p>\n","protected":false},"author":2,"featured_media":5369,"parent":649,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-4600","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/fmt.sym-biosis.co.jp\/en\/wp-json\/wp\/v2\/pages\/4600","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fmt.sym-biosis.co.jp\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/fmt.sym-biosis.co.jp\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/fmt.sym-biosis.co.jp\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/fmt.sym-biosis.co.jp\/en\/wp-json\/wp\/v2\/comments?post=4600"}],"version-history":[{"count":0,"href":"https:\/\/fmt.sym-biosis.co.jp\/en\/wp-json\/wp\/v2\/pages\/4600\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/fmt.sym-biosis.co.jp\/en\/wp-json\/wp\/v2\/pages\/649"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fmt.sym-biosis.co.jp\/en\/wp-json\/wp\/v2\/media\/5369"}],"wp:attachment":[{"href":"https:\/\/fmt.sym-biosis.co.jp\/en\/wp-json\/wp\/v2\/media?parent=4600"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}